I think the issues with overscreening are a really hard thing for most doctors to get, because they are extremely counterintuitive. @venkmurthy has some excellent tweetorials on issues similar to the (potential) overuse of CGM
True, but the patient group we looked at was an acute sample in an unhealthy population. The issue with screening is that it is all dependent on the denominator I'd have less issue with more use of CGM if it was only used by people with pre-diabetes/diabetes, for example
-
-
(In fact, we are advocating for more use of CGM for people with T2DM based on some prelim data that should be published soon. Not the same as general use for everyone though!)
-
If I had to summarize how I see the conflict between the "CGM camps", it's a philosophical disagreement: those who believe that until threshold of HbA1c of 6 is reached, no intervention is required. Versus those who believe HbA1c represents a continuum of risk.
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.